A London group’s analysis estimates tropical forests could offer a median $714 billion in commercial value from undiscovered drugs, with the Amazon alone worth about $215 billion. Deforestation since 2001 has already threatened substantial potential commercial and social value, while shortages of funding, access, and fair benefit-sharing hinder equitable development of medicines and protections for Indigenous knowledge and biodiversity.
